Medical and Pharmaceutical BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing BioMark showed the importance of expanding access to underserved and remote communities Joseph MortonNovember 13, 2025
Medical and Pharmaceutical BioMark Diagnostics reveals AI breakthrough in early lung cancer detection The model uses graph neural networks to interpret complex biological interactions Joseph MortonMay 20, 2025